Results 301 to 310 of about 488,279 (357)
Some of the next articles are maybe not open access.

Growth regulation by nerve growth factor

Molecular and Cellular Biochemistry, 1979
Although a great deal of descriptive information has been obtained about the actions of nerve growth factor on its target tissues, its structure, its receptors, and even its biosynthesis, there is no clear understanding, as yet, of the intracellular events mediating its transcriptional involvements.
T, Ikeno, G, Guroff
openaire   +2 more sources

Nerve growth factor as an angiogenic factor

Microvascular Research, 2008
Nerve growth factor (NGF), a neurotrophin that plays a crucial role in promoting neurotrophic and neurotropic effects in sympathetic neurons, has recently been identified as a novel angiogenic molecule, which exerts a variety of effects in the cardiovascular system and on endothelial cells.
BENAGIANO V   +4 more
openaire   +4 more sources

Nerve growth factor and nociception

Trends in Neurosciences, 1993
Nerve growth factor (NGF) is thought of as a target-derived factor responsible for the survival and maintaining the phenotype of specific sets of peripheral and central neurons during development and maturation. Recently, using physiological techniques, we have shown that specific functional types of nociceptive sensory neurons require NGF, first for ...
G R, Lewin, L M, Mendell
openaire   +2 more sources

On the immunology of nerve growth factor

Neuroscience Letters, 1985
We report some experiments on the immunological properties of nerve growth factor from the venom of Heloderma horridum and from bull seminal vesicles. On the basis of these results, taken together with results already in the literature, we propose an operational definition of the term nerve growth factor.
B E, Banks   +3 more
openaire   +2 more sources

Nerve growth factor revisited

Trends in Biochemical Sciences, 1993
Recent studies on nerve growth factor have revealed important new insights into the structure, function and evolution of this prototypical neurotrophic factor. Some of its features are (1) it has a unique three-dimensional fold that has since been found in two other growth factors, (2) it uses the trk proto-oncogene product, which has a tyrosine kinase,
R A, Bradshaw   +4 more
openaire   +2 more sources

Human nerve growth factor: Lack of immunocrossreactivity with mouse nerve growth factor

Life Sciences, 1980
Abstract Human β-nerve growth factor (hNGF) was purified from term human placenta. The biological potency of hNGF in the chick dorsal root ganglion assay did not differ significantly from that of mouse NGF (mNGF). Molecular weight determinations of mNGF and hMGF were also similar.
P, Walker, M E, Weichsel, D A, Fisher
openaire   +2 more sources

Inhibition of .beta. nerve growth factor binding to PC12 cells by .alpha. nerve growth factor and .gamma. nerve growth factor

Biochemistry, 1986
Pheochromocytoma (PC12) cells have been found to differ from dorsal root ganglionic cells with respect to the modulation of the beta nerve growth factor (beta NGF) binding properties elicited by alpha NGF and gamma NGF. In contrast to our previous results with intact dorsal root ganglionic cells in which only high-affinity binding was blocked, alpha ...
N R, Woodruff, K E, Neet
openaire   +2 more sources

The nerve growth factor family

Progress in Growth Factor Research, 1990
Nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) are small, basic, secretory proteins that allow the survival of specific neuronal populations. In their biologically active form, after cleavage from their biosynthetic precursors, these three neurotrophic proteins, or neurotrophins, show about 50% amino acid ...
openaire   +2 more sources

Receptors for Nerve Growth Factor

1993
Publisher Summary This chapter discusses the two receptors for nerve growth factor (NGF)—namely, (1) the low-affinity NGF receptor and (2) the product of the proto-oncogene trk . It also reviews the way they were originally identified and the structural and functional features of the two receptors.
M V, Chao, D S, Battleman, M, Benedetti
openaire   +2 more sources

Nerve Growth Factor and Pain

New England Journal of Medicine, 2010
Osteoarthritis, a common, painful condition, occurs at a rate of 1% per year and affects the majority of people who are over 55 years of age. In a proof-of-concept, phase 2 study in this issue of the Journal, Lane and colleagues1 report that blocking the activity of nerve growth factor with a neutralizing humanized monoclonal antibody (tanezumab) can ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy